Twist Bioscience stock climbs 2.58% as landmark gene therapy trial slashes cholesterol, Twist Bioscience states

Traders Union
All News
Business & Wealth
Companies
Twist Bioscience up 2.58% today

Highlights

TWST maintains strong bullish momentum, trading above all key moving averages with current price at the weekly high.
Momentum and trend indicators confirm robust buying pressure, but overbought signals suggest potential for near-term consolidation or pullback.
Expected weekly range is $93.00 to $105.00, with critical support at $91.35 and breakout resistance at $97.00.

One shot of the experimental therapy reduced 'bad' cholesterol by up to 62 percent. The findings were shared with a link to more information.

View post on X Loading...

The tweet was deleted by the author.

But we saved everything 🙂.

Bullish trend dominance as price holds well above support levels

TWST is trading well above its MA-20 ($94.67), MA-50 ($78.34), and MA-200 ($50.55), underscoring strong bullish momentum across all timeframes. The Ichimoku Kijun on D1 sits at $91.35, now serving as immediate support below the current price of $96.65. Near-term support is identified at the MA-20 ($94.67) and Ichimoku Kijun ($91.35), while key support is at the MA-50 ($78.34). Near-term resistance sits at the week’s high ($96.76) with the next key resistance at the MA-100 ($64.95), though this level is not immediately relevant given the current price and must be ignored if it is more than 30% below; thus, primary focus remains on the weekly high ($96.76) and the year’s peak as resistance.

Overbought momentum conditions as intraday gains test short-term resistance

Momentum signals remain strongly bullish on D1, as both MACD and ADX indicate robust buying pressure, supported by multiple timeframes. RSI at 56.57 sits in bullish territory, and CCI is neutral, while Stoch RSI and BBP both flag overbought conditions, indicating heightened buying activity and some risk of short-term exhaustion. In today's session, TWST has climbed 2.44 (2.58%), showcasing high intraday enthusiasm. Over the past week, the stock is up $2.80 (3.00%) from a prev_week_close of $93.85, with the current price positioned at the very top of the weekly range and weekly volatility standing at 13.57%. This marks steady upward momentum and a move toward short-term resistance, but signals also warn that the rally may be overextended in the near term.

Upside breakout favored as bullish signals outweigh pullback risk

Looking ahead, the expected price range for the coming week is $93.00 to $105.00, placing TWST just below its recent 52-week high of $105.41 and far above the 52-week low of $23.30. Based on strong Buy signals across RSI-W1, ADX-W1, MACD-W1, and MA-50-W1, the probability of further price increase is very high (more than 80%), making a further decline less likely. The baseline scenario projects a sideways consolidation between $93.00 and $100.00 as buyers and sellers balance at elevated levels. In the bullish scenario, a breakout above $97.00 could see the stock retesting $105.00 and potentially challenging the yearly high. Conversely, if selling pressure emerges, a pullback toward $94.00 could unfold, with $91.35 marking critical short-term support.

Previously it was reported that Twist Bioscience exhibited a firm bullish trend supported by strong underlying momentum, though ongoing price consolidation warranted close monitoring. The current analysis deepens this perspective by highlighting an emerging inflection point, with investors advised to closely watch for a confirmed breakout or reversal to signal the next directional move.

This material may contain third-party opinions, none of the data and information on this webpage constitutes investment advice according to our Disclaimer. While we adhere to strict Editorial Integrity, this post may contain references to products from our partners.